A multicenter phase 1/2 study investigating the safety, pharmacokinetics, pharmacodynamics and efficacy of a small molecule antimetabolite, RX-3117, plus nab-paclitaxel in pancreatic adenocarcinoma

Hani Babiker, Peter J. Schlegel, Lee G. Hicks, Andrea J. Bullock, Nafisa Burhani, Daruka Mahadevan, Emad Elquza, Mitesh J. Borad, Ely Benaim, Christine Peterson, Callie Heaton, Allyson J. Ocean

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'A multicenter phase 1/2 study investigating the safety, pharmacokinetics, pharmacodynamics and efficacy of a small molecule antimetabolite, RX-3117, plus nab-paclitaxel in pancreatic adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences